Literature DB >> 18392454

Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus.

S Chimeno Zoth1, E Gómez, E Carrillo, A Berinstein.   

Abstract

Newcastle disease virus (NDV) is the causative agent of an economically important disease, which affects all species of birds worldwide. Current vaccination programs for NDV include the use of either low-virulent live-virus vaccines or inactivated vaccines to induce protective immunity while producing minimal adverse effects in birds. In order to further characterize the immune response elicited by live virus and inactivated NDV conventional vaccines in chickens, we evaluated the presence of specific antibodies in different secretions and in tissue culture supernatants of immunized birds. To this end, we analyzed all the samples by ELISA, using an indirect assay set up in the laboratory. Specific anti-NDV IgG antibodies were detected in tracheal and cloacal swabs and tracheal and intestinal washes of immunized animals. We also found specific anti-NDV IgG antibodies in tracheal and intestinal tissue culture supernatants, indicating that the IgG found in swabs and washes was not transudated from serum or, at least, was not all transudated from serum. Knowledge about the mechanisms involved in the immune response of chickens to different NDV vaccines should increase our understanding of the mucosal response against the virus and, eventually, provide new useful information for the development and evaluation of synthetic vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392454     DOI: 10.1590/s0100-879x2008000400010

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  7 in total

1.  Newcastle disease virus vaccine encapsulated in biodegradable nanoparticles for mucosal delivery of a human vaccine.

Authors:  Yanwei Sun; Yang Zhang; Ci Shi; Wei Li; Gang Chen; Xiaohua Wang; Kai Zhao
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Potential use of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed in Rachiplusia nu larvae as an immunogen for chickens.

Authors:  Silvina Chimeno Zoth; Evangelina Gómez; Juan Manuel Carballeda; Oscar Taboga; Elisa Carrillo; Analía Berinstein
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

3.  Modulation of systemic and mucosal immunity against an inactivated vaccine of Newcastle disease virus by oral co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interleukin-18 and interferon-α.

Authors:  Md Masudur Rahman; Erdenebelig Uyangaa; Young Woo Han; Jin Hur; Sang-Youel Park; John Hwa Lee; Koanhoi Kim; Seong Kug Eo
Journal:  J Vet Med Sci       Date:  2014-12-11       Impact factor: 1.267

4.  IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.

Authors:  Kai Zhao; Guangyu Rong; Yan Hao; Lu Yu; Hong Kang; Xin Wang; Xiaohua Wang; Zheng Jin; Zhiyu Ren; Zejun Li
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

5.  Quantification and phenotypic characterisation of peripheral IFN-γ producing leucocytes in chickens vaccinated against Newcastle disease.

Authors:  S H Andersen; L Vervelde; K Sutton; L R Norup; E Wattrang; H R Juul-Madsen; T S Dalgaard
Journal:  Vet Immunol Immunopathol       Date:  2017-10-10       Impact factor: 2.046

6.  Induction of Mucosal Humoral Immunity by Subcutaneous Injection of an Oil-emulsion Vaccine against Salmonella enterica subsp. enterica serovar Enteritidis in Chickens.

Authors:  Yuuichi Ishida; Eishi Sakai; Katsuo Sato; Einori Sugiyama; Kazuyuki Mima; Akira Taneno; Hirofumi Shimomura; Longzhu Cui; Yoshikazu Hirai
Journal:  Food Saf (Tokyo)       Date:  2018-11-20

7.  Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.

Authors:  Kai Zhao; Gang Chen; Xing-Ming Shi; Ting-Ting Gao; Wei Li; Yan Zhao; Feng-Qiang Zhang; Jin Wu; Xianlan Cui; Yun-Feng Wang
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.